Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Metastatic Colorectal Cancer (CRC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Clinical Study Site, Mobile, Alabama, United States

  • Clinical Study Site, Tuscaloosa, Alabama, United States

  • Clinical Study Site, Goodyear, Arizona, United States

  • Clinical Study Site, Beverly Hills, California, United States

  • Clinical Study Site, Beverly Hills, California, United States

  • Clinical Study Site, Cerritos, California, United States

  • Clinical Study Site, Corona, California, United States

  • Clinical Study Site, Duarte, California, United States

  • Clinical Study Site, Fountain Valley, California, United States

  • Clinical Study Site, Huntington Beach, California, United States

  • Clinical Study Site, Irvine, California, United States

  • Clinical Study Site, Irvine, California, United States

  • Clinical Study Site, Los Angeles, California, United States

  • Clinical Study Site, Los Angeles, California, United States

  • Clinical Study Site, Los Angeles, California, United States

  • Clinical Study Site, Murrieta, California, United States

  • Clinical Study Site, Orange, California, United States

  • Clinical Study Site, Pasadena, California, United States

  • Clinical Study Site, Torrance, California, United States

  • Clinical Study Site, Upland, California, United States

  • Clinical Study Site, West Hollywood, California, United States

  • Clinical Study Site, Hartford, Connecticut, United States

  • Clinical Study Site, New Haven, Connecticut, United States

  • Clinical Study Site, Norwich, Connecticut, United States

  • Clinical Study Site, Newark, Delaware, United States

  • Clinical Study Site, Hialeah, Florida, United States

  • Clinical Study Site, Miami, Florida, United States

  • Clinical Study Site, Orlando, Florida, United States

  • Clinical Study Site, Plantation, Florida, United States

  • Clinical Study Site, Port Saint Lucie, Florida, United States

  • Clinical Study Site, St. Petersburg, Florida, United States

  • Clinical Study Site, Tamarac, Florida, United States

  • Clinical Study Site, Atlanta, Georgia, United States

  • Clinical Study Site, Atlanta, Georgia, United States

  • Clinical Study Site, Newnan, Georgia, United States

  • Clinical Study Site, Chicago, Illinois, United States

  • Clinical Study Site, Elmhurst, Illinois, United States

  • Clinical Study Site, O'Fallon, Illinois, United States

  • Clinical Study Site, Fort Wayne, Indiana, United States

  • Clinical Study Site, Indianapolis, Indiana, United States

  • Clinical Study Site, Westwood, Kansas, United States

  • Clinical Study Site, Edgewood, Kentucky, United States

  • Clinical Study Site, New Orleans, Louisiana, United States

  • Clinical Study Site, Baltimore, Maryland, United States

  • Clinical Study Site, Detroit, Michigan, United States

  • Clinical Study Site, Saint Louis Park, Minnesota, United States

  • Clinical Study Site, Springfield, Missouri, United States

  • Clinical Study Site, Billings, Montana, United States

  • Clinical Study Site, Lincoln, Nebraska, United States

  • Clinical Study Site, Lebanon, New Hampshire, United States

  • Clinical Study Site, New Brunswick, New Jersey, United States

  • Clinical Study Site, Mineola, New York, United States

  • Clinical Study Site, New York, New York, United States

  • Clinical Study Site, Rochester, New York, United States

  • Clinical Study Site, Syracuse, New York, United States

  • Clinical Study Site, The Bronx, New York, United States

  • Clinical Study Site, White Plains, New York, United States

  • Clinical Study Site, Akron, Ohio, United States

  • Clinical Study Site, Canton, Ohio, United States

  • Clinical Study Site, Cincinnati, Ohio, United States

  • Clinical Study Site, Cincinnati, Ohio, United States

  • Clinical Study Site, Cleveland, Ohio, United States

  • Clinical Study Site, Cleveland, Ohio, United States

  • Clinical Study Site, Mayfield Heights, Ohio, United States

  • Clinical Study Site, Oklahoma City, Oklahoma, United States

  • Clinical Study Site, Lebanon, Pennsylvania, United States

  • Clinical Study Site, Philadelphia, Pennsylvania, United States

  • Clinical Study Site, Philadelphia, Pennsylvania, United States

  • Clinical Study Site, Pittsburgh, Pennsylvania, United States

  • Clinical Study Site, Providence, Rhode Island, United States

  • Clinical Study Site, Greenville, South Carolina, United States

  • Clinical Study Site, Hermitage, Tennessee, United States

  • Clinical Study Site, Dallas, Texas, United States

  • Clinical Study Site, Dallas, Texas, United States

  • Clinical Study Site, Fort Worth, Texas, United States

  • Clinical Study Site, Tyler, Texas, United States

  • Clinical Study Site, Salt Lake City, Utah, United States

  • Clinical Study Site, Charlottesville, Virginia, United States

  • Clinical Study Site, Fairfax, Virginia, United States

  • Clinical Study Site, Spokane, Washington, United States

  • Clinical Study Site, Tacoma, Washington, United States

  • Clinical Study Site, Charleston, West Virginia, United States

  • Clinical Study Site, Madison, Wisconsin, United States

  • Clinical Study Site, Brussels, Belgium

  • Clinical Study Site, Ghent, Belgium

  • Clinical Study Site, Haine-Saint-Paul, Belgium

  • Clinical Study Site, Kortrijk, Belgium

  • Clinical Study Site, Toronto, Ontario, Canada

  • Clinical Study Site, Montreal, Quebec, Canada

  • Clinical Study Site, Regina, Saskatchewan, Canada

  • Clinical Study Site, Hradec Králové, Czechia

  • Clinical Study Site, Prague, Czechia

  • Clinical Study Site, Lyon, France

  • Clinical Study Site, Montpellier, France

  • Clinical Study Site, Nantes, France

  • Clinical Study Site, Paris, France

  • Clinical Study Site, Paris, France

  • Clinical Study Site, Pierre-Bénite, France

  • Clinical Study Site, Poitiers, France

  • Clinical Study Site, Strasbourg, France

  • Clinical Study Site, Bonn, Germany

  • Clinical Study Site, Hamburg, Germany

  • Clinical Study Site, Hamburg, Germany

  • Clinical Study Site, Meldola, Italy

  • Clinical Study Site, Osaka, Ontario, Japan

  • Clinical Study Site, Aichi, Japan

  • Clinical Study Site, Chiba, Japan

  • Clinical Study Site, Ehime, Japan

  • Clinical Study Site, Fukuoka, Japan

  • Clinical Study Site, Gifu, Japan

  • Clinical Study Site, Hiroshima, Japan

  • Clinical Study Site, Hokkaido, Japan

  • Clinical Study Site, Kawasaki, Japan

  • Clinical Study Site, Osaka, Japan

  • Clinical Study Site, Saitama, Japan

  • Clinical Study Site, Sendai, Japan

  • Clinical Study Site, Shizuoka, Japan

  • Clinical Study Site, Tokyo, Japan

  • Clinical Study Site, Tokyo, Japan

  • Clinical Study Site, Toyama, Japan

  • Clinical Study Site, Yokohama, Japan

  • Clinical Study Site, Rzeszów, Podkarpackie Voivodeship, Poland

  • Clinical Study Site, Warsaw, Poland

  • Clinical Study Site, Rio Piedras, Puerto Rico

  • Clinical Study Site, A Coruña, Spain

  • Clinical Study Site, Barcelona, Spain

  • Clinical Study Site, Barcelona, Spain

  • Clinical Study Site, Madrid, Spain

  • Clinical Study Site, Madrid, Spain

  • Clinical Study Site, Madrid, Spain

  • Clinical Study Site, Palma de Mallorca, Spain

  • Clinical Study Site, Santander, Spain

  • Clinical Study Site, Valencia, Spain

  • Clinical Study Site, Valencia, Spain

  • Clinical Study Site, Valencia, Spain

  • Clinical Study Site, Canterbury, England, United Kingdom

  • Clinical Study Site, London, England, United Kingdom

  • Clinical Study Site, Aberdeen, Scotland, United Kingdom

  • Clinical Study Site, Edinburgh, United Kingdom

  • Clinical Study Site, Manchester, United Kingdom